{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:39:13Z","timestamp":1787567953578,"version":"build-2736575974"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HI 1928\/5-1"],"award-info":[{"award-number":["HI 1928\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HI 1928\/6-1"],"award-info":[{"award-number":["HI 1928\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HI 1928\/14-1"],"award-info":[{"award-number":["HI 1928\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tardive dyskinesia (TD) is a persistent sensorimotor syndrome associated with antipsychotic exposure in schizophrenia spectrum disorders (SSD) and mood disorders (MOD), yet its neurobiological basis remains poorly understood. We investigated whether TD represents a distinct clinical and neurobiological phenotype across SSD and MOD. In this study, we examined a bicentric cohort of 453 individuals with SSD (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009360) or MOD (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200993), including early-psychosis (EP) and multiple-episode SSD patients. TD status was defined using Schooler and Kane criteria based on the Abnormal Involuntary Movement Scale (AIMS). Psychopathology was assessed with the Positive and Negative Syndrome Scale (PANSS). Structural MRI data were processed using FreeSurfer (v7.4.1). Propensity score matching was applied to compare TD-positive and TD-negative patients while controlling for age, sex, illness duration, antipsychotic dose, and PANSS scores. TD prevalence was 10.6% in multiple-episode SSD (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200931) and 7.5% in MOD (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20097), whereas no EP patients met criteria for TD. Logistic regression identified male sex (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.005) and higher PANSS general psychopathology scores (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.021) as independent predictors of TD. TD-positive patients showed reduced paracentral cortical surface area in both the matched SSD sample (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200986;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.006, corr.) and the combined transdiagnostic sample (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009179;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.024, corr.). These alterations were absent in EP patients. In conclusion, our findings suggest that TD is a transdiagnostic phenomenon, occurring in both SSD and MOD. However, TD in SSD appears to be associated with a distinct clinical and neurobiological phenotype, marked by greater illness severity, male predominance, and focal sensorimotor cortical alterations.\n                  <\/jats:p>","DOI":"10.1038\/s41537-026-00796-1","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:35:37Z","timestamp":1787560537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and neurobiological correlates of tardive dyskinesia in schizophrenia spectrum disorders and mood disorders"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5172-3303","authenticated-orcid":false,"given":"Dilsa Cemre Akkoc","family":"Altinok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4489-9125","authenticated-orcid":false,"given":"Sebastian","family":"Volkmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Fritze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geva A.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"W\u00f6lfl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Kukovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3601-7176","authenticated-orcid":false,"given":"Amanda","family":"Bellanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5590-3456","authenticated-orcid":false,"given":"Anastasia","family":"Pavlidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"von K\u00e4nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meyer-Lindenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4026-3561","authenticated-orcid":false,"given":"Sebastian","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1226-9800","authenticated-orcid":false,"given":"Dusan","family":"Hirjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"796_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/B978-0-12-381328-2.00009-2","volume":"98","author":"DE Tenback","year":"2011","unstructured":"Tenback, D. E. & van Harten, P. N. Epidemiology and risk factors for (tardive) dyskinesia. Int. Rev. Neurobiol. 98, 211\u2013230 (2011).","journal-title":"Int. Rev. Neurobiol."},{"key":"796_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1017\/S1092852922000992","volume":"28","author":"SN Caroff","year":"2023","unstructured":"Caroff, S. N. A new era in the diagnosis and treatment of tardive dyskinesia. CNS Spectr. 28, 401\u2013415 (2023).","journal-title":"CNS Spectr."},{"key":"796_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jns.2018.02.015","volume":"389","author":"SN Caroff","year":"2018","unstructured":"Caroff, S. N., Ungvari, G. S. & Owens, D. G. C. Historical perspectives on tardive dyskinesia. J. Neurol. Sci. 389, 4\u20139 (2018).","journal-title":"J. Neurol. Sci."},{"key":"796_CR4","unstructured":"Kraepelin, E. & Barclay, R. Dementia praecox. in The Clinical Roots of The Schizophrenia Concept: Translations of Seminal European Contributions on Schizophrenia 13\u201324 (Cambridge University Press, 1919)."},{"key":"796_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40263-018-0494-8","volume":"32","author":"K Stegmayer","year":"2018","unstructured":"Stegmayer, K., Walther, S. & van Harten, P. Tardive dyskinesia associated with atypical antipsychotics: prevalence, mechanisms and management strategies. CNS Drugs 32, 135\u2013147 (2018).","journal-title":"CNS Drugs"},{"key":"796_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/schbul\/sbn126","volume":"35","author":"PF Whitty","year":"2009","unstructured":"Whitty, P. F., Owoeye, O. & Waddington, J. L. Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr. Bull. 35, 415\u2013424 (2009).","journal-title":"Schizophr. Bull."},{"key":"796_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.schres.2025.09.021","volume":"285","author":"D Hirjak","year":"2025","unstructured":"Hirjak, D., Volkmer, S., Pokorny, V. & Mittal, VA. Advancing the sensori-\/psychomotor domain in schizophrenia spectrum disorders: From clinical observation to translational innovation. Schizophr Res. 285, 185\u2013195 (2025).","journal-title":"Schizophr Res."},{"key":"796_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1176\/appi.ajp.20250533","volume":"182","author":"D Hirjak","year":"2025","unstructured":"Hirjak, D., Mittal, VA., Meyer-Lindenberg, A. & Northoff, G. Future of Sensorimotor and Psychomotor Dysfunction in Mental Disorders: Emerging Tools, Methodological Challenges, and the Road Ahead. Am J Psychiatry 182, 807\u2013812 (2025).","journal-title":"Am J Psychiatry"},{"key":"796_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/j.1440-1614.2000.00737.x","volume":"34","author":"PS Sachdev","year":"2000","unstructured":"Sachdev, P. S. The current status of tardive dyskinesia. Aust. N. Z. J. Psychiatry 34, 355\u2013369 (2000).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"796_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.9758\/cpn.2020.18.4.493","volume":"18","author":"SN Caroff","year":"2020","unstructured":"Caroff, S. N. Recent advances in the pharmacology of tardive dyskinesia. Clin. Psychopharmacol. Neurosci. 18, 493\u2013506 (2020).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"796_CR11","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.4088\/JCP.16m11049","volume":"78","author":"CL Mentzel","year":"2017","unstructured":"Mentzel, C. L. et al. Effect of antipsychotic type and dose changes on tardive dyskinesia and parkinsonism severity in patients with a serious mental illness: the cura\u00e7ao extrapyramidal syndromes study XII. J. Clin. Psychiatry 78, e279\u2013e285 (2017).","journal-title":"J. Clin. Psychiatry"},{"key":"796_CR12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s40261-021-01060-3","volume":"41","author":"ML Zichlin","year":"2021","unstructured":"Zichlin, M. L., Mu, F., Leo, S. & Ayyagari, R. The impact of antipsychotic dose reduction on clinical outcomes and health care resource use among medicare patients with schizophrenia. Clin. Drug Investig. 41, 853\u2013863 (2021).","journal-title":"Clin. Drug Investig."},{"key":"796_CR13","first-page":"391","volume":"39","author":"SN Caroff","year":"2016","unstructured":"Caroff, S. N. & Campbell, E. C. Drug-induced extrapyramidal syndromes: implications for contemporary practice. Psychiatr. Clin. 39, 391\u2013411 (2016).","journal-title":"Psychiatr. Clin."},{"key":"796_CR14","unstructured":"Kane, J. M., Woerner, M., Weinhold, P., Wegner, J. & Kinon, B. Incidence of tardive dyskinesia: five-year data from prospective study. Psychopharmacol. Bull. 20, 39\u201340 (1984)."},{"key":"796_CR15","first-page":"20738","volume":"78","author":"JM Kane","year":"2017","unstructured":"Kane, J. M., Correll, C. U., Carbon, M. & Hsieh, C.-H. Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis. J. Clin. Psychiatry 78, 20738 (2017).","journal-title":"J. Clin. Psychiatry"},{"key":"796_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/wps.20579","volume":"17","author":"M Carbon","year":"2018","unstructured":"Carbon, M., Kane, J. M., Leucht, S. & Correll, C. U. Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis. World Psychiatry 17, 330\u2013340 (2018).","journal-title":"World Psychiatry"},{"key":"796_CR17","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.4088\/JCP.16r10832","volume":"78","author":"M Carbon","year":"2017","unstructured":"Carbon, M., Hsieh, C. H., Kane, J. M. & Correll, C. U. Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis. J. Clin. Psychiatry 78, e264\u2013e278 (2017).","journal-title":"J. Clin. Psychiatry"},{"key":"796_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-06780-w","volume":"25","author":"K Griffiths","year":"2025","unstructured":"Griffiths, K. et al. Identifying the diagnostic gap of tardive dyskinesia: an analysis of semi-structured electronic health record data. BMC Psychiatry 25, 407 (2025).","journal-title":"BMC Psychiatry"},{"key":"796_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2025.11.017","volume":"104","author":"C Colosimo","year":"2026","unstructured":"Colosimo, C., Jain, R., Duma, K., Kurzeja, A. & Arango, C. A European perspective on tardive dyskinesia. Eur. Neuropsychopharmacol. 104, 112740 (2026).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"796_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/schbul\/sbp105","volume":"36","author":"GS Ungvari","year":"2010","unstructured":"Ungvari, G. S., Caroff, S. N. & Gerevich, J. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr. Bull. 36, 231\u2013238 (2010).","journal-title":"Schizophr. Bull."},{"key":"796_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.schres.2015.10.022","volume":"169","author":"D Hirjak","year":"2015","unstructured":"Hirjak, D. et al. Motor dysfunction within the schizophrenia-spectrum: a dimensional step towards an underappreciated domain. Schizophr. Res. 169, 217\u2013233 (2015).","journal-title":"Schizophr. Res."},{"key":"796_CR22","doi-asserted-by":"crossref","unstructured":"Walther, S. & Strik W. Motor symptoms and schizophrenia. Neuropsychobiology 66, 77\u201392 (2012).","DOI":"10.1159\/000339456"},{"key":"796_CR23","first-page":"10","volume":"61","author":"WS Fenton","year":"2000","unstructured":"Fenton, W. S. Prevalence of spontaneous dyskinesia in schizophrenia. J. Clin. Psychiatry 61, 10\u201314 (2000).","journal-title":"J. Clin. Psychiatry"},{"key":"796_CR24","doi-asserted-by":"crossref","unstructured":"Kalniunas, A., James, K., & Pappa, S. Prevalence of spontaneous movement disorders (dyskinesia, parkinsonism, akathisia and dystonia) in never-treated patients with chronic and first-episode psychosis: a systematic review and meta-analysis. BMJ Ment Health 27, e301184 (2024).","DOI":"10.1136\/bmjment-2024-301184"},{"key":"796_CR25","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/schbul\/sbn146","volume":"36","author":"JP Koning","year":"2010","unstructured":"Koning, J. P. et al. Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophr. Bull. 36, 723\u2013731 (2010).","journal-title":"Schizophr. Bull."},{"key":"796_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.psychres.2011.01.005","volume":"188","author":"JP Koning","year":"2011","unstructured":"Koning, J. P., Kahn, R. S., Tenback, D. E., van Schelven, L. J. & van Harten, P. N. Movement disorders in nonpsychotic siblings of patients with nonaffective psychosis. Psychiatry Res. 188, 133\u2013137 (2011).","journal-title":"Psychiatry Res."},{"key":"796_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.schres.2016.04.032","volume":"174","author":"J Kindler","year":"2016","unstructured":"Kindler, J. et al. Abnormal involuntary movements are linked to psychosis-risk in children and adolescents: results of a population-based study. Schizophr. Res. 174, 58\u201364 (2016).","journal-title":"Schizophr. Res."},{"key":"796_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/archgenpsychiatry.2007.23","volume":"65","author":"VA Mittal","year":"2008","unstructured":"Mittal, V. A., Neumann, C., Saczawa, M. & Walker, E. F. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Arch. Gen. Psychiatry 65, 165\u2013171 (2008).","journal-title":"Arch. Gen. Psychiatry"},{"key":"796_CR29","doi-asserted-by":"crossref","unstructured":"Cunningham Owens, D. A Guide To The Extrapyramidal Side Effects of Antipsychotic Drugs (Cambridge University Press, 2014).","DOI":"10.1017\/CBO9781139149112"},{"key":"796_CR30","doi-asserted-by":"crossref","unstructured":"Peralta, V. & Cuesta, M. J. The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone, or olanzapine. Prim. Care Companion. J. Clin. Psychiatry 12, PCC.09m00799 (2010)","DOI":"10.4088\/PCC.09m00799gry"},{"key":"796_CR31","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.4088\/JCP.v69n1008","volume":"69","author":"H Ascher-Svanum","year":"2008","unstructured":"Ascher-Svanum, H. et al. Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study. J. Clin. Psychiatry 69, 1580 (2008).","journal-title":"J. Clin. Psychiatry"},{"key":"796_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0920-9964(97)00058-3","volume":"26","author":"PN van Harten","year":"1997","unstructured":"van Harten, P. N., Hoek, H. W., Matroos, G. E., Koeter, M. & Kahn, R. S. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curacao Extrapyramidal Syndromes Study II. Schizophr. Res. 26, 235\u2013242 (1997).","journal-title":"Schizophr. Res."},{"key":"796_CR33","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.4088\/JCP.v64n0913","volume":"64","author":"PP Oosthuizen","year":"2003","unstructured":"Oosthuizen, P. P., Emsley, R. A., Maritz, J. S., Turner, J. A. & Keyter, N. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol. J. Clin. Psychiatry 64, 1075\u20131080 (2003).","journal-title":"J. Clin. Psychiatry"},{"key":"796_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-0447.1997.tb10153.x","volume":"96","author":"J van Os","year":"1997","unstructured":"van Os, J. et al. Tardive dyskinesia: who is at risk? Acta Psychiatr. Scand. 96, 206\u2013216 (1997).","journal-title":"Acta Psychiatr. Scand."},{"key":"796_CR35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S2215-0366(20)30264-9","volume":"7","author":"JM Rubio","year":"2020","unstructured":"Rubio, J. M. et al. Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis. Lancet Psychiatry 7, 749\u2013761 (2020).","journal-title":"Lancet Psychiatry"},{"key":"796_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.schres.2005.07.034","volume":"80","author":"DD Miller","year":"2005","unstructured":"Miller, D. D. et al. Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. Schizophr. Res. 80, 33\u201343 (2005).","journal-title":"Schizophr. Res."},{"key":"796_CR37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/schbul\/sbn146","volume":"36","author":"JP Koning","year":"2008","unstructured":"Koning, J. P. et al. Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophr. Bull. 36, 723\u2013731 (2008).","journal-title":"Schizophr. Bull."},{"key":"796_CR38","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1007\/s11136-019-02269-8","volume":"28","author":"J McEvoy","year":"2019","unstructured":"McEvoy, J. et al. Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia. Qual. Life Res. 28, 3303\u20133312 (2019).","journal-title":"Qual. Life Res."},{"key":"796_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/JCP.0000000000001532","volume":"42","author":"M Gardea-Resendez","year":"2022","unstructured":"Gardea-Resendez, M. et al. Clinical phenotype of tardive dyskinesia in bipolar disorder. J. Clin. Psychopharmacol. 42, 159\u2013162 (2022).","journal-title":"J. Clin. Psychopharmacol."},{"key":"796_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/S0033291700020900","volume":"15","author":"D Owens","year":"1985","unstructured":"Owens, D. et al. Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations. Psychol. Med. 15, 27\u201341 (1985).","journal-title":"Psychol. Med."},{"key":"796_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0925-4927(91)90007-D","volume":"40","author":"CC Mion","year":"1991","unstructured":"Mion, C. C., Andreasen, N. C., Arndt, S., Swayze, I. I. V. W. & Cohen, G. A. MRI abnormalities in tardive dyskinesia. Psychiatry Res. Neuroimaging 40, 157\u2013166 (1991).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"796_CR42","doi-asserted-by":"crossref","unstructured":"Elkashef, A. M., Buchanan, R. W., Gellad, F., Munson, R. C. & Breier, A. Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study. Am. J. Psychiatry 151, 752\u20135 (1994).","DOI":"10.1176\/ajp.151.5.752"},{"key":"796_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0925-4927(95)02591-K","volume":"61","author":"P Buckley","year":"1995","unstructured":"Buckley, P. et al. Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia. Psychiatry Res. 61, 95\u2013102 (1995).","journal-title":"Psychiatry Res."},{"key":"796_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1192\/bjp.167.1.41","volume":"167","author":"JL Waddington","year":"1995","unstructured":"Waddington, J. L. et al. Tardive dyskinesia in schizophrenia: relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging. Br. J. Psychiatry 167, 41\u201344 (1995).","journal-title":"Br. J. Psychiatry"},{"key":"796_CR45","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/archpsyc.59.4.332","volume":"59","author":"RG McCreadie","year":"2002","unstructured":"McCreadie, R. G., Thara, R., Padmavati, R., Srinivasan, T. N. & Jaipurkar, S. D. Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. Arch. Gen. Psychiatry 59, 332\u2013336 (2002).","journal-title":"Arch. Gen. Psychiatry"},{"key":"796_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0893-133X(00)00172-X","volume":"24","author":"FE Scheepers","year":"2001","unstructured":"Scheepers, F. E. et al. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology 24, 47\u201354 (2001).","journal-title":"Neuropsychopharmacology"},{"key":"796_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1192\/bjp.bp.112.114538","volume":"203","author":"S Sarr\u00f3","year":"2013","unstructured":"Sarr\u00f3, S. et al. Structural brain changes associated with tardive dyskinesia in schizophrenia. Br. J. Psychiatry 203, 51\u201357 (2013).","journal-title":"Br. J. Psychiatry"},{"key":"796_CR48","doi-asserted-by":"publisher","first-page":"e71034","DOI":"10.1371\/journal.pone.0071034","volume":"8","author":"CT Li","year":"2013","unstructured":"Li, C. T. et al. Gray matter abnormalities in schizophrenia patients with tardive dyskinesia: a magnetic resonance imaging voxel-based morphometry study. PLoS ONE 8, e71034 (2013).","journal-title":"PLoS ONE"},{"key":"796_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31186-y","volume":"8","author":"T Yu","year":"2018","unstructured":"Yu, T. et al. Decreased gray matter volume of cuneus and lingual gyrus in schizophrenia patients with tardive dyskinesia is associated with abnormal involuntary movement. Sci. Rep. 8, 12884 (2018).","journal-title":"Sci. Rep."},{"key":"796_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.schres.2009.02.003","volume":"109","author":"YM Bai","year":"2009","unstructured":"Bai, Y. M. et al. White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study. Schizophr. Res. 109, 167\u2013181 (2009).","journal-title":"Schizophr. Res."},{"key":"796_CR51","doi-asserted-by":"crossref","unstructured":"Sakreida, K. et al. Disentangling dyskinesia from parkinsonism in motor structures of patients with schizophrenia. Brain Commun. 4, fcac190 (2022).","DOI":"10.1093\/braincomms\/fcac190"},{"key":"796_CR52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuroscience.2018.06.014","volume":"385","author":"P Zhang","year":"2018","unstructured":"Zhang, P. et al. Resting-state brain activity changes associated with tardive dyskinesia in patients with schizophrenia: fractional amplitude of low-frequency fluctuation decreased in the occipital lobe. Neuroscience 385, 237\u2013245 (2018).","journal-title":"Neuroscience"},{"key":"796_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-37396-z","volume":"16","author":"T Yu","year":"2026","unstructured":"Yu, T. et al. Decreased N-acetylaspartate plus N-acetyl-aspartyl-glutamate levels in the caudate of schizophrenia patients with tardive dyskinesia. Sci. Rep. 16, 6773 (2026).","journal-title":"Sci. Rep."},{"key":"796_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2023.111724","volume":"335","author":"T Yu","year":"2023","unstructured":"Yu, T. et al. Regional Homogeneity in schizophrenia patients with tardive dyskinesia: a resting-state fMRI study. Psychiatry Res. Neuroimaging 335, 111724 (2023).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"796_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135548","volume":"742","author":"T Yu","year":"2021","unstructured":"Yu, T. et al. Abnormal functional connectivity of motor circuit in the schizophrenic patients with tardive dyskinesia: a resting-state fMRI study. Neurosci. Lett. 742, 135548 (2021).","journal-title":"Neurosci. Lett."},{"key":"796_CR56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.schres.2019.07.032","volume":"212","author":"J Kindler","year":"2019","unstructured":"Kindler, J. et al. Functional and structural correlates of abnormal involuntary movements in psychosis risk and first episode psychosis. Schizophr. Res. 212, 196\u2013203 (2019).","journal-title":"Schizophr. Res."},{"key":"796_CR57","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/schbul\/sbac170","volume":"49","author":"N Nadesalingam","year":"2023","unstructured":"Nadesalingam, N. et al. The behavioral mapping of psychomotor slowing in psychosis demonstrates heterogeneity among patients suggesting distinct pathobiology. Schizophr. Bull. 49, 507\u2013517 (2023).","journal-title":"Schizophr. Bull."},{"key":"796_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2026.112808","volume":"108","author":"JL Waddington","year":"2026","unstructured":"Waddington, J. L. Involuntary movements integral to psychotic illness: a \u2018circular epistemological journey\u2019 informing the pathobiology and treatment of psychosis and reconceptualising tardive dyskinesia. Eur. Neuropsychopharmacol. 108, 112808 (2026).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"796_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1194222","volume":"14","author":"A Baminiwatta","year":"2023","unstructured":"Baminiwatta, A. & Correll, C. U. Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications. Front. Psychiatry 14, 1194222 (2023).","journal-title":"Front. Psychiatry"},{"key":"796_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","volume":"39","author":"NR Schooler","year":"1982","unstructured":"Schooler, N. R. & Kane, J. M. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry 39, 486\u2013487 (1982).","journal-title":"Arch. Gen. Psychiatry"},{"key":"#cr-split#-796_CR61.1","doi-asserted-by":"crossref","unstructured":"Guy, W. ECDEU Assessment Manual for Psychopharmacology: Revised 1976","DOI":"10.1037\/e591322011-001"},{"key":"#cr-split#-796_CR61.2","unstructured":"534-537 (DHEW publication number ADM 76-338, 1976)."},{"key":"796_CR62","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay, S. R., Fiszbein, A. & Opler, L. A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261\u2013276 (1987).","journal-title":"Schizophr. Bull."},{"key":"796_CR63","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/schbul\/sbu001","volume":"40","author":"S Leucht","year":"2014","unstructured":"Leucht, S. et al. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr. Bull. 40, 314\u2013326 (2014).","journal-title":"Schizophr. Bull."},{"key":"796_CR64","first-page":"179","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale, A. M., Fischl, B. & Sereno, M. I. Cortical surface-based analysis. I. Segment. Surf. Reconstruct. Neuroimage 9, 179\u2013194 (1999).","journal-title":"I. Segment. Surf. Reconstruct. Neuroimage"},{"key":"796_CR65","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl, B. & Dale, A. M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. USA 97, 11050\u201311055 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"796_CR66","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodol.) 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B (Methodol.)"},{"key":"796_CR67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/YCO.0b013e3282f53132","volume":"21","author":"CU Correll","year":"2008","unstructured":"Correll, C. U. & Schenk, E. M. Tardive dyskinesia and new antipsychotics. Curr. Opin. Psychiatry 21, 151\u2013156 (2008).","journal-title":"Curr. Opin. Psychiatry"},{"key":"796_CR68","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00787-006-0544-5","volume":"15","author":"S Gebhardt","year":"2006","unstructured":"Gebhardt, S. et al. Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment. Eur. Child Adolesc. Psychiatry 15, 371\u2013382 (2006).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"796_CR69","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/JCP.0b013e31828bf059","volume":"33","author":"DM Blumberger","year":"2013","unstructured":"Blumberger, D. M. et al. The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression. J. Clin. Psychopharmacol. 33, 391\u2013397 (2013).","journal-title":"J. Clin. Psychopharmacol."},{"key":"796_CR70","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ajp.2017.12.001","volume":"32","author":"TM Rajan","year":"2018","unstructured":"Rajan, T. M., Bharadwaj, B., Rajkumar, R. P. & Adole, P. S. Frequency and correlates of tardive dyskinesia in Indian patients with type I bipolar disorder. Asian J. Psychiatr. 32, 92\u201398 (2018).","journal-title":"Asian J. Psychiatr."},{"key":"796_CR71","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jad.2013.04.053","volume":"150","author":"J Coplan","year":"2013","unstructured":"Coplan, J., Gugger, J. J. & Tasleem, H. Tardive dyskinesia from atypical antipsychotic agents in patients with mood disorders in a clinical setting. J. Affect Disord. 150, 868\u2013871 (2013).","journal-title":"J. Affect Disord."},{"key":"796_CR72","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1055\/s-0033-1354407","volume":"46","author":"Y Lee","year":"2013","unstructured":"Lee, Y., Lin, P. Y., Chang, Y. Y., Chong, M. Y. & Cheng, A. T. Antidepressant-induced tardive syndrome: a retrospective epidemiological study. Pharmacopsychiatry 46, 281\u2013285 (2013).","journal-title":"Pharmacopsychiatry"},{"key":"796_CR73","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4088\/JCP.09m05793yel","volume":"72","author":"SN Caroff","year":"2011","unstructured":"Caroff, S. N. et al. Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia. J. Clin. Psychiatry 72, 295\u2013303 (2011).","journal-title":"J. Clin. Psychiatry"},{"key":"796_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102877","volume":"66","author":"K Uludag","year":"2021","unstructured":"Uludag, K. et al. Prevalence, clinical correlates and risk factors associated with Tardive Dyskinesia in Chinese patients with schizophrenia. Asian J. Psychiatr. 66, 102877 (2021).","journal-title":"Asian J. Psychiatr."},{"key":"796_CR75","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/schbul\/sbae153","volume":"51","author":"N Nadesalingam","year":"2024","unstructured":"Nadesalingam, N. et al. Testing a motor score based on PANSS ratings: a proxy for comprehensive motor assessment. Schizophr. Bull. 51, 1162\u20131172 (2024).","journal-title":"Schizophr. Bull."},{"key":"796_CR76","doi-asserted-by":"crossref","unstructured":"Kane, J. M., Woerner, M. & Lieberman, J. Tardive dyskinesia: prevalence, incidence, and risk factors. J. Clin. Psychopharmacol. 8, 72\u20138 (1988).","DOI":"10.1007\/978-3-642-70140-5_9"},{"key":"796_CR77","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/schbul\/18.4.701","volume":"18","author":"R Yassa","year":"1992","unstructured":"Yassa, R. & Jeste, D. V. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr. Bull. 18, 701\u2013715 (1992).","journal-title":"Schizophr. Bull."},{"key":"796_CR78","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2018.02.012","volume":"389","author":"M Solmi","year":"2018","unstructured":"Solmi, M., Pigato, G., Kane, J. M. & Correll, C. U. Clinical risk factors for the development of tardive dyskinesia. J. Neurol. Sci. 389, 21\u201327 (2018).","journal-title":"J. Neurol. Sci."},{"key":"796_CR79","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.schres.2023.03.034","volume":"255","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia. Schizophr. Res. 255, 140\u2013147 (2023).","journal-title":"Schizophr. Res."},{"key":"796_CR80","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jpsychires.2022.04.029","volume":"151","author":"Q Liang","year":"2022","unstructured":"Liang, Q. et al. Tardive dyskinesia in Chinese patients with schizophrenia: prevalence, clinical correlates and relationship with cognitive impairment. J. Psychiatr. Res. 151, 181\u2013187 (2022).","journal-title":"J. Psychiatr. Res."},{"key":"796_CR81","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/070674370204700504","volume":"47","author":"S Grigoriadis","year":"2002","unstructured":"Grigoriadis, S. & Seeman, M. V. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can. J. Psychiatry 47, 437\u2013442 (2002).","journal-title":"Can. J. Psychiatry"},{"key":"796_CR82","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000067808","volume":"46","author":"IC Lai","year":"2002","unstructured":"Lai, I. C. et al. Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia. Neuropsychobiology 46, 173\u2013175 (2002).","journal-title":"Neuropsychobiology"},{"key":"796_CR83","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/oxfordjournals.schbul.a006902","volume":"27","author":"B Ismail","year":"2001","unstructured":"Ismail, B., Cantor-Graae, E. & McNeil, T. F. Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings. Schizophr. Bull. 27, 629\u2013641 (2001).","journal-title":"Schizophr. Bull."},{"key":"796_CR84","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.yic.0000182120.51672.7d","volume":"21","author":"J Eberhard","year":"2006","unstructured":"Eberhard, J., Lindstr\u00f6m, E. & Levander, S. Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course. Int. Clin. Psychopharmacol. 21, 35\u201342 (2006).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"796_CR85","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.schres.2007.10.018","volume":"100","author":"J Modestin","year":"2008","unstructured":"Modestin, J., Wehrli, M. V., Stephan, P. L. & Agarwalla, P. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment. Schizophr. Res. 100, 97\u2013107 (2008).","journal-title":"Schizophr. Res."},{"key":"796_CR86","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.psychres.2018.12.007","volume":"272","author":"JS Kent","year":"2019","unstructured":"Kent, J. S. et al. Instrument-based assessment of motor function yields no evidence of dyskinesia in adult first-degree biological relatives of individuals with schizophrenia and schizoaffective disorder. Psychiatry Res. 272, 135\u2013140 (2019).","journal-title":"Psychiatry Res."},{"key":"796_CR87","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/archpsyc.1982.04290040052008","volume":"39","author":"DC Owens","year":"1982","unstructured":"Owens, D. C., Johnstone, E. C. & Frith, C. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch. Gen. Psychiatry 39, 452\u2013461 (1982).","journal-title":"Arch. Gen. Psychiatry"},{"key":"796_CR88","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/00004714-198210000-00010","volume":"2","author":"TJ Crow","year":"1982","unstructured":"Crow, T. J. et al. Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors? J. Clin. Psychopharmacol. 2, 336\u2013340 (1982).","journal-title":"J. Clin. Psychopharmacol."},{"key":"796_CR89","doi-asserted-by":"crossref","unstructured":"Joseph, A. et al. Schizophrenia and disordered sensorimotor control: challenges, mechanisms and opportunities. Brain 149, 2200\u20132223 (2026).","DOI":"10.1093\/brain\/awag064"},{"key":"796_CR90","unstructured":"Banker, L. & Tadi, P. Neuroanatomy, Precentral Gyrus, StatPearls Publishing (2023)."},{"key":"796_CR91","unstructured":"Hathaway, W. R. & Newton, B. W. Neuroanatomy, Prefrontal Cortex, StatPearls Publishing (2023)."},{"key":"796_CR92","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41380-020-0814-5","volume":"26","author":"G Northoff","year":"2021","unstructured":"Northoff, G., Hirjak, D., Wolf, R. C., Magioncalda, P. & Martino, M. All roads lead to the motor cortex: psychomotor mechanisms and their biochemical modulation in psychiatric disorders. Mol. Psychiatry 26, 92\u2013102 (2021).","journal-title":"Mol. Psychiatry"},{"key":"796_CR93","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/schbul\/sbab133","volume":"48","author":"KSF Damme","year":"2022","unstructured":"Damme, K. S. F. et al. Depression and psychosis risk shared vulnerability for motor signs across development, symptom dimensions, and familial risk. Schizophr. Bull. 48, 752\u2013762 (2022).","journal-title":"Schizophr. Bull."},{"key":"796_CR94","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/schbul\/sbac003","volume":"48","author":"S Walther","year":"2022","unstructured":"Walther, S. & Mittal, V. A. Motor behavior is relevant for understanding mechanism, bolstering prediction, and improving treatment: a transdiagnostic perspective. Schizophr. Bull. 48, 741\u2013748 (2022).","journal-title":"Schizophr. Bull."},{"key":"796_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107295","volume":"133","author":"K Frei","year":"2025","unstructured":"Frei, K. et al. Tardive dyskinesia versus tardive syndrome. What is in a name? Parkinsonism Relat. Disord. 133, 107295 (2025).","journal-title":"Parkinsonism Relat. Disord."},{"key":"796_CR96","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/JCP.0b013e31828f62b0","volume":"33","author":"V Peralta","year":"2013","unstructured":"Peralta, V., de Jal\u00f3n, E. G., Campos, M. S. & Cuesta, M. J. Phenomenological differences between spontaneous and drug-related extrapyramidal syndromes in patients with schizophrenia-spectrum disorders. J. Clin. Psychopharmacol. 33, 438\u2013440 (2013).","journal-title":"J. Clin. Psychopharmacol."},{"key":"796_CR97","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.schres.2010.08.002","volume":"123","author":"VA Mittal","year":"2010","unstructured":"Mittal, V. A. et al. Striatal volumes and dyskinetic movements in youth at high-risk for psychosis. Schizophr. Res. 123, 68\u201370 (2010).","journal-title":"Schizophr. Res."},{"key":"796_CR98","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41380-023-02356-w","volume":"29","author":"M Martino","year":"2024","unstructured":"Martino, M. & Magioncalda, P. A three-dimensional model of neural activity and phenomenal-behavioral patterns. Mol. Psychiatry 29, 639\u2013652 (2024).","journal-title":"Mol. Psychiatry"},{"key":"796_CR99","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.schres.2020.01.009","volume":"218","author":"P Magioncalda","year":"2020","unstructured":"Magioncalda, P. et al. Intrinsic brain activity of subcortical-cortical sensorimotor system and psychomotor alterations in schizophrenia and bipolar disorder: a preliminary study. Schizophr. Res. 218, 157\u2013165 (2020).","journal-title":"Schizophr. Res."},{"key":"796_CR100","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1002\/hbm.24755","volume":"40","author":"D Hirjak","year":"2019","unstructured":"Hirjak, D. et al. Patterns of co-altered brain structure and function underlying neurological soft signs in schizophrenia spectrum disorders. Hum. Brain Mapp. 40, 5029\u20135041 (2019).","journal-title":"Hum. Brain Mapp."},{"key":"796_CR101","doi-asserted-by":"publisher","first-page":"110370","DOI":"10.1016\/j.pnpbp.2021.110370","volume":"111","author":"D Hirjak","year":"2021","unstructured":"Hirjak, D. et al. Progress in sensorimotor neuroscience of schizophrenia spectrum disorders: lessons learned and future directions. Prog. Neuro Psychopharmacol. Biol. Psychiatry 111, 110370\u2013110370 (2021).","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"796_CR102","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1192\/bja.2018.46","volume":"25","author":"DC Owens","year":"2019","unstructured":"Owens, D. C. Tardive dyskinesia update: treatment and management. BJPsych Adv. 25, 78\u201389 (2019).","journal-title":"BJPsych Adv."},{"key":"796_CR103","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0074-7742(08)60282-2","volume":"31","author":"JL Waddington","year":"1989","unstructured":"Waddington, J. L. Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms. Int. Rev. Neurobiol. 31, 297\u2013353 (1989).","journal-title":"Int. Rev. Neurobiol."},{"key":"796_CR104","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0920-9964(99)00220-0","volume":"49","author":"J Quinn","year":"2001","unstructured":"Quinn, J. et al. Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction. Schizophr. Res. 49, 79\u201387 (2001).","journal-title":"Schizophr. Res."},{"key":"796_CR105","doi-asserted-by":"crossref","unstructured":"Akkoc Altinok, D. C. et al. Clinical and neurobiological characterization of akathisia in schizophrenia spectrum disorders and mood disorders. Biol. Psychiatry Cogn. Neurosci. Neuroimaging, 17:S2451-9022(26)00176-X (2026).","DOI":"10.1016\/j.bpsc.2026.06.002"}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-026-00796-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-026-00796-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-026-00796-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:02:11Z","timestamp":1787565731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-026-00796-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1038\/s41537-026-00796-1","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.H. has received honoraria from Rovi and Teva, speaker fees from DGPPN and editorial fees from Elsevier and Thieme Verlag. A.M-.L. has received consultant fees from: Agence Nationale de la Recherche, Brain Mind Institute, Brainsway, CISSN (Catania International Summer School of Neuroscience), Daimler und Benz Stiftung, Fondation FondaMental, Hector Stiftung II, Janssen-Cilag GmbH, Lundbeck A\/S, Lundbeckfonden, Lundbeck Int. Neuroscience Foundation, MedinCell, Sage Therapeutics, Techspert.io, The LOOP Z\u00fcrich, University Medical Center Utrecht, von Behring-R\u00f6ntgen-Stiftung. AM-L has received speaker fees from: Arztekammer Nordrhein, BAG Psychiatrie Oberbayern, Biotest\u00a8 AG, Forum Werkstatt Karlsruhe, International Society of Psychiatric Genetics, Brentwood, Klinik f\u00fcr Psychiatrie und Psychotherapie Ingolstadt, Lundbeck SAS France, med Update GmbH, Merz-Stiftung, Siemens Healthineers, Society of Biological Psychiatry. A.M-.L. has received editorial fees from: American Association for the Advancement of Science, Elsevier, Thieme Verlag. The other authors have declared that there are no conflicts of interest in relation to the subject of this study.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"69"}}